zoledronic acid has been researched along with Periodontal Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, T; Ohshige, H; Shiraki, M; Taguchi, A; Tanaka, S | 1 |
| Kaklamanos, EG; Papadopoulos, MA; Yavropoulou, MP; Zymperdikas, VF | 1 |
| Bafaloukos, D; Karagianni, A; Linardou, H; Michalakakou, K; Nicolatou-Galitis, O; Papadopoulou, E; Papassotiriou, I; Tarampikou, A; Tsixlakis, K; Vardas, E | 1 |
| Leung, WK; Li, CL; Lu, WW; Seneviratne, CJ; Zheng, LW; Zwahlen, RA | 1 |
| Galiti, D; Galitis, E; Karampeazis, A; Labropoulos, S; Migliorati, C; Nicolatou-Galitis, O; Razis, E; Sgouros, J; Tsimpidakis, A | 1 |
| Bargagli, G; Francini, E; Francini, F; Miano, ST; Pascucci, A; Petrioli, R; Ruggiero, G | 1 |
2 review(s) available for zoledronic acid and Periodontal Diseases
| Article | Year |
|---|---|
Bisphosphonates as Supplement to Dental Treatment: A Network Meta-Analysis.
Topics: Bone Diseases; Diphosphonates; Humans; Network Meta-Analysis; Periodontal Diseases; Zoledronic Acid | 2021 |
Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.
Topics: Aged; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Fatal Outcome; Female; Humans; Ibandronic Acid; Imidazoles; Male; Middle Aged; Neoplasms; Periodontal Diseases; Radiography, Panoramic; Retrospective Studies; Tooth Extraction; Zoledronic Acid | 2015 |
1 trial(s) available for zoledronic acid and Periodontal Diseases
| Article | Year |
|---|---|
Improved periodontal disease and prevention of tooth loss in osteoporosis patients receiving once-yearly zoledronic acid: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Drug Administration Schedule; Female; Humans; Male; Osteoporosis; Periodontal Diseases; Tooth Loss; Treatment Outcome; Zoledronic Acid | 2019 |
3 other study(ies) available for zoledronic acid and Periodontal Diseases
| Article | Year |
|---|---|
The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab.
Topics: Aged; Aged, 80 and over; Bevacizumab; Biomarkers; Drug Therapy, Combination; Female; Gingival Crevicular Fluid; Humans; Inflammation; Interleukin-17; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; Osteonecrosis; Periodontal Diseases; Periodontal Pocket; Predictive Value of Tests; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2020 |
Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats.
Topics: Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Disease Models, Animal; Disease Progression; Female; Imidazoles; Ovariectomy; Periodontal Diseases; Random Allocation; Rats; Rats, Sprague-Dawley; X-Ray Microtomography; Zoledronic Acid | 2016 |
Osteonecrosis of the jaw in patients with cancer who received zoledronic acid and bevacizumab.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Collagen Type I; Dental Care; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Jaw Diseases; Lung Neoplasms; Male; Middle Aged; Osteonecrosis; Peptides; Periodontal Diseases; Radiography, Panoramic; Risk Factors; Tooth Extraction; Zoledronic Acid | 2011 |